Symprove

What Symprove does

Symprove Ltd is a UK-based consumer health company that develops, manufactures, and sells a patented, water-based liquid probiotic supplement containing four proprietary bacterial strains (Lactobacillus acidophilus NCIMB 30175, Lactobacillus plantarum NCIMB 30173, Lactobacillus rhamnosus NCIMB 30174, and Enterococcus lactis NCIMB 30176). Its core technology is a 21-hour precision fermentation process in a germinated barley extract suspension that keeps bacteria metabolically active rather than freeze-dried, validated to deliver 99.3% of bacteria alive to the gut within 10 minutes in a SHIME in-vitro model. The product is positioned as a clinically evidenced alternative to capsule probiotics and is supported by 15 independent published studies at institutions including UCL, King's College London, and ProDigest.

The business operates a product-led growth model centred on a rolling 4-weekly subscription (£49.99) with ancillary loyalty tiers (6-month and 12-month at £39.99/month), one-off 4-week (£79.99) and 12-week (£149.99) packs, and travel/accessory add-ons. Distribution is primarily direct-to-consumer via the Shopify-powered symprove.com website with ReCharge-managed subscriptions, supplemented by a nationwide listing in 426 Tesco stores (April 2026) and Meaghers Pharmacy as the Ireland retail partner. Marketing emphasises content (The Gut Hub, The Gut Diaries podcast), influencer partnerships, refer-a-friend mechanics via Mention Me, and an Impact-managed affiliate programme.

Symprove was founded in 2002 by Barry Smith and was owned by private equity firm bd-capital from 2020 until January 2026, when Metagenics (backed by Gryphon Investors) completed the acquisition and concurrent strategic debt recapitalisation. Under bd-capital the company grew at approximately 30% year-on-year for five years, reaching nearly £30 million in 2024 revenue, and was claimed to be Europe's largest subscription business in the probiotic category and the UK's No.1 live and active bacteria supplement by Euromonitor retail value sales (2025 data).

Name

Symprove

Legal name

Symprove Ltd

Website

https://symprove.com

Company type

Private

Founded year

2002

Operating status

Acquired

Headcount range

101–250 employees

Short description

Symprove Ltd is a UK-based consumer health company that sells a patented, water-based liquid probiotic supplement via DTC subscriptions, one-off packs, and a 426-store Tesco retail listing to individual consumers seeking clinically evidenced gut health support.

Ownership category

akta.pro rank

Headquarters

HQ city

Farnham

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Marketing or Sales, Personnel, Technology or R&D, Supply Chain

Revenue model

1. Rolling Subscription (Monthly): Rolling 4-weekly subscription delivered every 4 weeks at £49.99. Customers can pause, skip, or cancel anytime with free delivery. The subscription auto-renews and is the primary revenue driver, representing Europe's largest subscription business in the probiotic category under bd-capital ownership.
2. One-time product purchases: One-off purchases of 4-week packs (£79.99) or 12-week packs (£149.99) for customers not ready to commit to a subscription. Available internationally with shipping to most countries.
3. Loyalty Subscription (12-month): 12-month fixed-term subscription at £39.99/month with 13 deliveries of 4 bottles each. Auto-renews to rolling subscription at end of term. Includes exclusive deals and competitions not available to standard subscribers.
4. Shot glass and travel pack add-ons: Accessory products including the Symprove shot glass (£6.99) and On The Go travel packs available as add-ons to subscriptions or one-off purchases, driving incremental revenue per customer.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Core offering

Symprove manufactures and sells a patented, water-based liquid probiotic supplement containing four proprietary live bacterial strains, formulated to deliver metabolically active bacteria past stomach acid to the gut within 10 minutes. The product is sold primarily through a rolling monthly subscription model with a 12-month loyalty tier and one-off 4-week and 12-week packs, complemented by a travel pack (Symprove On The Go) and a branded shot glass accessory.

Product overview

Symprove is a single-product health supplement company offering a patented water-based probiotic formulation. The core product is the Symprove probiotic supplement, a liquid formulation containing four proprietary bacterial strains designed to reach the gut alive. The product is available in four flavours (Original, Strawberry and Raspberry, Mango and Passion Fruit, and Pineapple) with multiple purchase options including rolling subscriptions, loyalty subscriptions, and one-time purchases. Supplementary offerings include the Symprove On The Go travel pack and the Symprove Shot Glass accessory. The company operates on a direct-to-consumer subscription model with recent retail expansion into Tesco stores following acquisition by Metagenics.

Differentiator

Problem solved

Functional benefit

Products and services

• Symprove Probiotic Supplement Patented water-based liquid probiotic supplement containing four proprietary live bacterial strains (Lactobacillus acidophilus, L. plantarum, L. rhamnosus, Enterococcus lactis) delivered as a daily 70ml morning shot. Designed for UK adult consumers seeking clinically validated gut health support. Available in Original, Strawberry and Raspberry, Mango and Passion Fruit, and Pineapple flavours via subscription or one-off purchase.
• Symprove On The Go

Quantifiable outcome

• 94% of customers feel the difference within 12 weeks (2021 survey of 490 Symprove customers)
• +6 more outcomes

Named customers6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Tesco Accelerator ProgrammecoreGTM or Marketing Partner · 1 April 2026Symprove was selected for Tesco's Accelerator Programme in April 2026 following its recent nationwide listing in 426 Tesco stores. The programme provides strategic support and increased visibility to help accelerate distribution of the high-growth challenger brand in the gut health category. The launch is backed by promotional activity and marketing plans targeting wellness-focused shoppers seeking clinically proven solutions.
• MetagenicscoreStrategic or Co-development Partner · 1 January 2026In January 2026, Metagenics (backed by private equity firm Gryphon Investors) completed the acquisition of Symprove, the UK's leading probiotic brand, from bd-capital. The acquisition integrates Symprove's clinically proven, water-based probiotic formulation into Metagenics' global portfolio of practitioner-recommended supplements, with plans to expand the brand's reach into new markets worldwide. Concurrent with the acquisition, Metagenics and Gryphon completed a strategic debt recapitalization to fund continued organic and M&A growth. The deal followed Metagenics' 2022 purchase of Nutri Advanced, consolidating its position in the UK health supplements market.
• Meaghers PharmacyminorChannel Partner/ Reseller/ DistributorMeaghers Pharmacy is identified as Symprove's trusted retail partner for customers browsing from Ireland. When customers access the Symprove website from Ireland, they are redirected to Meaghers Pharmacy for purchases. This is the exclusive retail partner for the Republic of Ireland market.

Scale indicators10 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Bio-Kult: UK-based multi-strain probiotic supplement brand owned by ADM Protexin. Directly comparable as a competing UK probiotic brand with capsule and sachet formats, sold through similar health retailers and DTC channels.
• Optibac Probiotics: UK-based probiotics specialist offering strain-specific supplements for various conditions. Directly competes with Symprove in the UK DTC probiotic market with similar subscription and one-off purchase models.
• BioGaia: Swedish probiotics company with proprietary Lactobacillus reuteri strains, publicly listed. Comparable as a science-backed probiotic specialist operating globally with both consumer health and pediatric product lines.

Broad incumbents

• Yakult: Global leader in fermented probiotic dairy drinks, owned by Yakult Honsha. Comparable as a mass-market probiotic beverage brand, though operating at much larger scale with a dairy-based (vs. water-based) delivery system.
• Actimel (Danone): Danone's probiotic yogurt drink brand, one of the most recognized probiotic products in UK/Europe. Comparable as a mass-market liquid probiotic beverage, though category-leading scale and dairy-based format differ from Symprove's water-based approach.
• Culturelle: Probiotic supplement brand owned by DSM-Firmenich (formerly i-Health). Comparable as a leading single-strain probiotic brand (Lactobacillus rhamnosus GG) marketed via retail and DTC channels for digestive health.
• Align (Procter & Gamble): Procter & Gamble's probiotic brand featuring Bifidobacterium longum 35624. Comparable as a flagship CPG-company probiotic brand targeting digestive health, with significant clinical research backing.

Emerging players

• Vivomixx (Alflorex): Medical-grade probiotic brand featuring the 35624 strain. Comparable as a clinically proven single-strain probiotic brand sold through pharmacies and DTC in UK/Ireland, often positioned for IBS management.
• Pendulum Therapeutics: US-based probiotics company focused on microbiome science with strain-specific formulations for metabolic health. Comparable as a science-driven, DTC-focused probiotic brand with clinical claims and subscription models.

Others

• Metagenics: Symprove's parent company and practitioner-recommended supplement brand operating globally. Acquired Symprove in January 2026 to consolidate UK probiotic market position and integrate with Nutri Advanced (UK nutritional supplement subsidiary).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/groups/SymproveCustomerCommunity
• Instagraminstagram.com/symproveyourlife
• Xx.com/symprove

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symprove